Qaialdo Unión Europea - español - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - espironolactona - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 y 5.

ESPIRONOLACTONA COMPRIMIDOS 25 mg Chile - español - ISPC (Instituto de Salud Pública de Chile)

espironolactona comprimidos 25 mg

recben xenerics farmacÉutica ltda. - espironolactona - sin formulas